ORMP News & Mentions

Popular stocks:

Mullen Automotive

TOP stocks:

Shares of other companies:

Cornerstone Strategic Value Fund

DISH Network

Suncor Energy

Charles River Laboratories International

Ready Capital

Philip Morris

Virgin Orbit Holdings

Bitfarms

Tencent Music Entertainment

Hour Loop

Oramed Pharmaceuticals (ORMP) Stock Forecast for 2023 – 2026. Sell or Buy?

Last update: May 11, 2023 (19:23)

Sector: Healthcare

The share price of Oramed Pharmaceuticals Inc. (ORMP) now

What analysts predict: $3.15

52-week High/Low: $13.73 / $1.81

50/200 Day Moving Average: $3.225 / $3.889

This figure corresponds to the Average Price over the previous 50/200 days. For Oramed Pharmaceuticals stocks, the 50-day moving average is the resistance level today.

For Oramed Pharmaceuticals stocks, the 200-day moving average is the resistance level today.

Are you interested in Oramed Pharmaceuticals Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Oramed Pharmaceuticals stock price in 2023, 2024, 2025, 2026, 2027. How much will one Oramed Pharmaceuticals share be worth in 2023 - 2027?

When should I take profit in Oramed Pharmaceuticals stock? When should I record a loss on Oramed Pharmaceuticals stock? What are analysts' forecasts for Oramed Pharmaceuticals stock? What is the future of Oramed Pharmaceuticals stock? We forecast Oramed Pharmaceuticals stock performance using neural networks based on historical data on Oramed Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Oramed Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Oramed Pharmaceuticals shares. This happens once a day.

Historical and forecast chart of Oramed Pharmaceuticals stock

The chart below shows the historical price of Oramed Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Oramed Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Subscribe for Forecasts Update!

Oramed Pharmaceuticals daily forecast for a month

Date	Target	Pes.	Opt.	Vol., %
May 08	2.22	2.19	2.27	3.82
May 09	2.26	2.25	2.30	2.30
May 10	2.28	2.23	2.33	4.07
May 11	2.31	2.26	2.37	4.91
May 12	2.29	2.25	2.33	3.67
May 13	2.28	2.26	2.32	2.71
May 14	2.31	2.28	2.36	3.49
May 15	2.35	2.31	2.39	3.54
May 16	2.31	2.28	2.37	4.18
May 17	2.34	2.29	2.38	3.87
May 18	2.34	2.31	2.40	3.61
May 19	2.33	2.30	2.37	3.04
May 20	2.30	2.25	2.36	5.16
May 21	2.29	2.22	2.33	4.74
May 22	2.25	2.18	2.29	5.03
May 23	2.33	2.31	2.39	3.60
May 24	2.36	2.33	2.40	3.24
May 25	2.35	2.28	2.42	5.89
May 26	2.30	2.27	2.36	3.72
May 27	2.24	2.22	2.30	3.96
May 28	2.24	2.17	2.28	4.75
May 29	2.27	2.24	2.32	3.57
May 30	2.25	2.22	2.31	4.21
May 31	2.22	2.19	2.24	2.18
Jun 01	2.17	2.13	2.23	4.40
Jun 02	2.25	2.23	2.32	4.09
Jun 03	2.23	2.17	2.28	5.10
Jun 04	2.14	2.07	2.16	4.21
Jun 05	2.12	2.09	2.17	3.73
Jun 06	2.03	1.98	2.09	5.71

Oramed Pharmaceuticals Daily Price Targets

Oramed Pharmaceuticals Stock Forecast 05-08-2023.

Forecast target price for 05-08-2023: $2.22.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.678%.
Pessimistic target level: 2.19
Optimistic target level: 2.27

Oramed Pharmaceuticals Stock Forecast 05-09-2023.

Forecast target price for 05-09-2023: $2.26.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.247%.
Pessimistic target level: 2.25
Optimistic target level: 2.30

Oramed Pharmaceuticals Stock Forecast 05-10-2023.

Forecast target price for 05-10-2023: $2.28.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.915%.
Pessimistic target level: 2.23
Optimistic target level: 2.33

Oramed Pharmaceuticals Stock Forecast 05-11-2023.

Forecast target price for 05-11-2023: $2.31.
Positive dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 4.677%.
Pessimistic target level: 2.26
Optimistic target level: 2.37

Oramed Pharmaceuticals Stock Forecast 05-12-2023.

Forecast target price for 05-12-2023: $2.29.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 3.543%.
Pessimistic target level: 2.25
Optimistic target level: 2.33

Oramed Pharmaceuticals Stock Forecast 05-13-2023.

Forecast target price for 05-13-2023: $2.28.
Negative dynamics for Oramed Pharmaceuticals shares will prevail with possible volatility of 2.636%.
Pessimistic target level: 2.26
Optimistic target level: 2.32

ORMP (ORMP) Monthly Stock Prediction for 2023

Month	Target	Pes.	Opt.	Vol., %
Oct.	2.48	2.32	2.56	9.44
Nov.	2.40	2.18	2.67	18.47
Dec.	2.22	2.15	2.41	10.79

Full forecast for 2023

Oramed Pharmaceuticals forecast for this year

Oramed Pharmaceuticals Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $2.48084. Pessimistic: $2.32. Optimistic: $2.56

Oramed Pharmaceuticals Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $2.40269. Pessimistic: $2.18. Optimistic: $2.67

Oramed Pharmaceuticals Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $2.22249. Pessimistic: $2.15. Optimistic: $2.41

Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2024

Month	Target	Pes.	Opt.	Vol., %
Jan	1.99	1.79	2.12	15.64
Feb	1.96	1.84	2.02	8.99
Mar	2.10	2.01	2.21	9.12
Apr	2.22	2.14	2.40	10.96
May	2.15	1.90	2.27	16.25
Jun	2.13	2.01	2.21	9.38
Jul	2.45	2.24	2.55	12.36
Aug	2.35	2.14	2.46	13.17
Sep	2.45	2.24	2.54	11.87
Oct	2.65	2.38	2.74	12.94
Nov	2.92	2.67	3.08	13.38
Dec	3.33	3.04	3.62	16.01

Full forecast for 2024

Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2025

Month	Target	Pes.	Opt.	Vol., %
Jan	3.42	3.26	3.66	10.93
Feb	3.48	3.34	3.72	10.38
Mar	3.25	3.08	3.39	9.33
Apr	3.63	3.46	3.92	11.67
May	3.26	3.02	3.43	11.97
Jun	2.95	2.61	3.26	19.95
Jul	3.01	2.80	3.37	16.74
Aug	2.69	2.36	2.89	18.14
Sep	2.67	2.38	2.95	19.28
Oct	2.96	2.82	3.10	9.00
Nov	2.88	2.64	3.18	17.24
Dec	2.69	2.42	2.91	16.81

Full forecast for 2025

Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2026

Month	Target	Pes.	Opt.	Vol., %
Jan	2.59	2.46	2.68	8.13
Feb	2.46	2.28	2.63	13.47
Mar	2.15	1.96	2.23	12.00
Apr	2.12	1.99	2.22	10.43
May	2.11	1.96	2.24	12.45
Jun	2.11	1.98	2.24	11.48
Jul	2.05	1.95	2.29	14.66
Aug	2.30	2.03	2.54	19.93
Sep	2.14	2.02	2.33	13.39
Oct	2.32	2.24	2.50	10.31
Nov	2.44	2.22	2.73	18.53
Dec	2.66	2.34	2.88	18.71

Full forecast for 2026

Oramed Pharmaceuticals (ORMP) Monthly Stock Prediction for 2027

Month	Target	Pes.	Opt.	Vol., %
Jan	2.70	2.38	2.78	14.54
Feb	2.84	2.59	3.10	16.47
Mar	3.04	2.88	3.40	15.06
Apr	2.84	2.63	2.97	11.34
May	2.86	2.60	3.01	13.64
Jun	2.77	2.56	3.11	17.54
Jul	2.59	2.47	2.84	12.73
Aug	2.63	2.37	2.90	18.38
Sep	2.66	2.34	2.92	19.90
Oct	2.54	2.24	2.72	17.49
Nov	2.81	2.58	3.07	16.06
Dec	2.95	2.80	3.28	14.68

Full forecast for 2027

Oramed Pharmaceuticals information and performance

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Oramed Pharmaceuticals Address

HI-TECH PARK 2/4 GIVAT-RAM, PO BOX 39098, JERUSALEM, IL

Market Capitalization: 116 800 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -26 807 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.54

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: N/A

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 60.11

Enterprise Value (EV) /Revenue

EV To EBITDA: -6.13

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 40275700

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A

Related stocks from Healthcare sector

Novavax, Inc. (NVAX)

Zynex, Inc. (ZYXI)

Tilray, Inc. (TLRY)

Fate Therapeutics, Inc. (FATE)

Rockwell Medical, Inc. (RMTI)

Cumberland Pharmaceuticals Inc. (CPIX)

Veeva Systems Inc. (VEEV)

Convey Holding Parent, Inc. (CNVY)

Eargo, Inc. (EAR)

Zynerba Pharmaceuticals, Inc. (ZYNE)

Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.

<img data-src="/images/stock/ORMP.svg" class="img_30 lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img class="img_30" src="/images/stock/ORMP.svg"> Oramed Pharmaceuticals (ORMP) Stock Forecast for 2023 – 2026. Sell or Buy?